tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

DAWN Stock Latest News

Day One Biopharmaceuticals price target lowered to $21 from $24 at BofA
The FlyDay One Biopharmaceuticals price target lowered to $21 from $24 at BofA
2d ago
DAWN
Promising Outlook for Day One Biopharmaceuticals: Buy Rating Driven by Ojemda’s Market Potential
PremiumRatings
Promising Outlook for Day One Biopharmaceuticals: Buy Rating Driven by Ojemda’s Market Potential
16d ago
DAWN
Buy Rating for Day One Biopharmaceuticals: Strong Financial Position and Strategic Growth Potential
PremiumRatings
Buy Rating for Day One Biopharmaceuticals: Strong Financial Position and Strategic Growth Potential
1M ago
DAWN
Day One Biopharmaceuticals price target lowered to $34 from $39 at JPMorgan
PremiumThe Fly
Day One Biopharmaceuticals price target lowered to $34 from $39 at JPMorgan
1M ago
DAWN
Day One Biopharma’s Earnings Call Highlights Growth and Challenges
PremiumCompany Announcements
Day One Biopharma’s Earnings Call Highlights Growth and Challenges
2M ago
DAWN
Day One price target lowered to $30 from $34 at JonesResearch
PremiumThe FlyDay One price target lowered to $30 from $34 at JonesResearch
2M ago
DAWN
Buy Rating on Day One Biopharmaceuticals: Strong Performance and Promising Future Prospects
Premium
Ratings
Buy Rating on Day One Biopharmaceuticals: Strong Performance and Promising Future Prospects
2M ago
DAWN
Promising Growth Potential for Day One Biopharmaceuticals Driven by Ojemda and FIREFLY-2 Trial
Premium
Ratings
Promising Growth Potential for Day One Biopharmaceuticals Driven by Ojemda and FIREFLY-2 Trial
2M ago
DAWN
Promising Growth and Strategic Advancements Drive Buy Rating for Day One Biopharmaceuticals
PremiumRatings
Promising Growth and Strategic Advancements Drive Buy Rating for Day One Biopharmaceuticals
2M ago
DAWN
Day One price target lowered to $36 from $40 at H.C. Wainwright
PremiumThe Fly
Day One price target lowered to $36 from $40 at H.C. Wainwright
2M ago
DAWN
Buy Rating Affirmed for Day One Biopharmaceuticals: Strategic Growth and Pipeline Expansion Drive Positive Outlook
PremiumRatings
Buy Rating Affirmed for Day One Biopharmaceuticals: Strategic Growth and Pipeline Expansion Drive Positive Outlook
2M ago
DAWN
Day One Biopharmaceuticals Reports Strong 2024 Results
PremiumCompany Announcements
Day One Biopharmaceuticals Reports Strong 2024 Results
2M ago
DAWN
Promising Growth and Strategic Positioning Justify Buy Rating for Day One Biopharmaceuticals
PremiumRatingsPromising Growth and Strategic Positioning Justify Buy Rating for Day One Biopharmaceuticals
2M ago
DAWN
Day One Biopharmaceuticals Reports 2024 Financial Results
Premium
Company Announcements
Day One Biopharmaceuticals Reports 2024 Financial Results
2M ago
8K
DAWN
Day One Biopharmaceuticals reports Q4 EPS ($1.02), consensus (35c)
Premium
The Fly
Day One Biopharmaceuticals reports Q4 EPS ($1.02), consensus (35c)
2M ago
DAWN
DAWN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
DAWN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
DAWN
Optimistic Buy Rating for Day One Biopharmaceuticals Driven by Strong Ojemda Performance and Promising Pipeline
PremiumRatings
Optimistic Buy Rating for Day One Biopharmaceuticals Driven by Strong Ojemda Performance and Promising Pipeline
2M ago
DAWN
Day One Biopharmaceuticals Reports 2024 Financial Results
PremiumCompany Announcements
Day One Biopharmaceuticals Reports 2024 Financial Results
3M ago
8K
DAWN
Day One reports preliminary 2024 OJEMDA product revenue of $57.2M
PremiumThe Fly
Day One reports preliminary 2024 OJEMDA product revenue of $57.2M
3M ago
DAWN
Day One Biopharmaceuticals preliminary FY24 OJEMDA product revenue $57.2M
PremiumThe FlyDay One Biopharmaceuticals preliminary FY24 OJEMDA product revenue $57.2M
3M ago
DAWN
Day One Biopharmaceuticals price target lowered to $25 from $28 at BofA
Premium
The Fly
Day One Biopharmaceuticals price target lowered to $25 from $28 at BofA
3M ago
DAWN
Day One Biopharmaceuticals (DAWN) Posts Stellar Q3 but with Extreme Concentration Risk
Premium
Market News
Day One Biopharmaceuticals (DAWN) Posts Stellar Q3 but with Extreme Concentration Risk
4M ago
IPN
DAWN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >